On April 26, 2021 Nmune Bio, Inc. (NASDAQ: INMB) (the "Company" or "INmune"), a clinical-stage immunology company focused on developing treatments that harness a patient’s innate immune system to fight disease, reported that Raymond J. Tesi, MD, President and CEO, will participate in a fireside chat at the B Riley Neuroscience Conference on Wednesday, April 28 (Press release, INmune Bio, APR 26, 2021, View Source [SID1234578468]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

B Riley Neurosciences Conference
Fireside Chat Date: Wednesday, April 28, 2021
Presentation Time: 1:00 PM Eastern Time
Webcast: View Source

Please contact your representative at B Riley to schedule a virtual one-on-one meeting with INmune Bio during the respective conference.